Liu Yinong, Lai Lizu, Wilhelm Sabine, Phillips Katharine A, Guo Yunxiao, Greenberg Jennifer L, Ren Zhihong
Key Laboratory of Adolescent Cyberpsychology And Behavior (Ministry Of Education), Key Laboratory of Human Development and Mental Health Of Hubei Province, School of Psychology, Central China Normal University, Wuhan, China.
Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Psychol Med. 2024 Dec 3;54(15):1-14. doi: 10.1017/S0033291724002733.
This meta-analysis and trial sequential analysis (TSA) of randomized controlled trials (RCTs) on the psychological treatment of body dysmorphic disorder (BDD) was conducted to evaluate the intervention effects and robustness of the evidence. This study included 15 RCTs up until 15 June 2024, with 905 participants. Results showed significant improvements in BDD symptoms ( = -0.97), depression ( = -0.51), anxiety ( = -0.72), insight/delusion ( = -0.57), psychosocial functioning ( = 0.45), and quality of life ( = 0.44), with effects sustained from 1 to 6 months follow-up. RCTs with a waitlist/inactive control reported larger effect sizes for post-intervention BDD symptoms compared to those with a placebo/active control group. In addition, studies with low risk of bias demonstrate larger effect sizes for post-intervention psychosocial functioning compared to studies with some concerns. Notably, the presence of exposure and response prevention in the treatment, as well as the mode of delivery (face-to-face or digital), did not have a significant impact on the intervention outcomes. Females exhibited greater effect sizes in post-intervention BDD symptoms and psychosocial functioning than males. With increasing age, the effect size for insight/delusion symptoms diminished. Longer session duration was associated with larger effect sizes for BDD symptoms, depression at post-treatment, and depression at follow-up. TSA indicated robust evidence for depression at post-treatment and BDD symptoms, while the remaining outcome variables did not meet the desired level of evidence. In conclusion, this study underscores the effectiveness of psychological treatments in reducing BDD symptoms and improving related outcomes, highlighting the need for further research to confirm the impact of these therapies on other outcomes.
本项对身体变形障碍(BDD)心理治疗的随机对照试验(RCT)进行的荟萃分析和试验序贯分析(TSA)旨在评估干预效果及证据的稳健性。本研究纳入了截至2024年6月15日的15项RCT,共905名参与者。结果显示,BDD症状( = -0.97)、抑郁( = -0.51)、焦虑( = -0.72)、洞察力/妄想( = -0.57)、心理社会功能( = 0.45)和生活质量( = 0.44)均有显著改善,且效果在随访1至6个月时持续存在。与采用安慰剂/积极对照组的试验相比,采用等待名单/无干预对照组的RCT在干预后BDD症状方面报告的效应量更大。此外,与存在一些问题的研究相比,偏倚风险低的研究在干预后心理社会功能方面显示出更大的效应量。值得注意的是,治疗中暴露与反应阻止的存在以及提供方式(面对面或数字化)对干预结果没有显著影响。女性在干预后BDD症状和心理社会功能方面的效应量大于男性。随着年龄增长,洞察力/妄想症状的效应量减小。疗程持续时间越长,BDD症状、治疗后抑郁和随访时抑郁的效应量越大。TSA表明治疗后抑郁和BDD症状有稳健的证据,而其余结局变量未达到期望的证据水平。总之,本研究强调了心理治疗在减轻BDD症状和改善相关结局方面的有效性,突出了需要进一步研究以确认这些疗法对其他结局的影响。